Spansules Formulations India Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.95 Cr
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 31.74 Cr
About Spansules Formulations India
Spansules Formulations India Private Limited (SFIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2022 (Two years and ten months 26 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.95 Cr.
The company currently has active open charges totaling ₹31.74 Cr.
Venkata Guttikonda, Rama Guttikonda, Haswanth Guttikonda, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230TG2022PTC160441
-
Company No.
160441
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2022
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Spansules Formulations India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haswanth Guttikonda
|
Director | 09-Mar-2022 | Current |
|
Venkata Guttikonda
|
Director | 09-Mar-2022 | Current |
|
Rama Guttikonda
|
Director | 09-Mar-2022 | Current |
|
Harika Guttikonda
|
Director | 09-Mar-2022 | Current |
Financial Performance of Spansules Formulations India.
Spansules Formulations India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spansules Formulations India?
In 2023, Spansules Formulations India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vyaghra Health Foods Private LimitedHaswanth Guttikonda and Harika Guttikonda are mutual person
-
Jeevan Scientific Technology LimitedVenkata Guttikonda is a mutual person
-
Spansules Pharmatech Private LimitedVenkata Guttikonda, Rama Guttikonda and 2 more are mutual person
-
Spansules Formulations Private Limited
Rama Guttikonda and Haswanth Guttikonda are mutual person
-
Int Cellulose LlpVenkata Guttikonda and Haswanth Guttikonda are mutual person
-
Spansules Life Sciences Private Limited
Venkata Guttikonda, Rama Guttikonda and 2 more are mutual person
Charges (Loans)
₹31.74 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 29.24 Cr
- Axis Bank Limited : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2023 | Axis Bank Limited | ₹2.50 Cr | Open |
| 01 Oct 2022 | Hdfc Bank Limited | ₹28.44 Cr | Open |
| 10 Jun 2022 | Hdfc Bank Limited | ₹8.01 M | Open |
How Many Employees Work at Spansules Formulations India?
Spansules Formulations India has a workforce of 57 employees as of May 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spansules Formulations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansules Formulations India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.